A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

被引：379
|
作者：
Cobleigh, MA
Langmuir, VK
Sledge, GW
Miller, KD
Haney, L
Novotny, WF
Reimann, JD
Vassel, A
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Genentech Inc, San Francisco, CA USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2003.08.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 124
页数：8
相关论文
共 50 条
  • [1] Phase II dose escalation trial of Avastin™ (bevacizumab) in women with previously treated metastatic breast cancer.
    Cobleigh, MA
    Miller, KD
    Langmuir, VK
    Reimann, JD
    Vassel, AV
    Novotny, WF
    Sledge, GW
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 301 - 301
  • [2] A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer - DEREGULATE study - Trial in progress
    Kawaguchi, K.
    Nishitai, R.
    Manaka, D.
    Ota, T.
    Nishikawa, Y.
    Kudo, R.
    An, H.
    Hamasu, S.
    Konishi, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Dose-escalation of REgorafenib for patients with previously treated metastatic colorectal cancer - DEREGULATE study
    Nishitai, Ryuta
    Manaka, Dai
    Amaike, Hisashi
    Nozaki, Akira
    Kanai, Masashi
    Yamaguchi, Daisuke
    Yazawa, Takeshi
    Kawashima, Kazuhiko
    Ikeda, Fusao
    ANNALS OF ONCOLOGY, 2015, 26 : 129 - 130
  • [4] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    T Sakiyama
    J Tsurutani
    T Iwasa
    H Kawakami
    Y Nonagase
    T Yoshida
    K Tanaka
    Y Fujisaka
    T Kurata
    Y Komoike
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2015, 112 : 819 - 824
  • [5] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    Sakiyama, T.
    Tsurutani, J.
    Iwasa, T.
    Kawakami, H.
    Nonagase, Y.
    Yoshida, T.
    Tanaka, K.
    Fujisaka, Y.
    Kurata, T.
    Komoike, Y.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 819 - 824
  • [6] Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur uracil
    Osaki, Akihiko
    Mitsuyama, Shoshu
    Kurebayashi, Jun-Ichi
    Sonoo, Hiroshi
    Nishimura, Reiki
    Koga, Toshihiro
    Murakami, Shigeru
    Ohno, Shinji
    ONCOLOGY LETTERS, 2010, 1 (01) : 45 - 49
  • [7] A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
    Erica L. Mayer
    M. E. Scheulen
    J. Beckman
    H. Richly
    A. Duarte
    M. M. Cotreau
    A. L. Strahs
    S. Agarwal
    L. Steelman
    E. P. Winer
    M. N. Dickler
    Breast Cancer Research and Treatment, 2013, 140 : 331 - 339
  • [8] A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
    Mayer, Erica L.
    Scheulen, M. E.
    Beckman, J.
    Richly, H.
    Duarte, A.
    Cotreau, M. M.
    Strahs, A. L.
    Agarwal, S.
    Steelman, L.
    Winer, E. P.
    Dickler, M. N.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (02) : 331 - 339
  • [9] A Phase I Dose-escalation Clinical Trial of Bronchoscopic Cryoimmunotherapy
    Velez, A.
    Laniado, I.
    Schluger, R.
    Demaio, A.
    Murthy, V.
    Bessich, J. L.
    Lukovnikova, A.
    Blaisdell, M.
    Krolikowski, K.
    Tsay, J. J.
    Segal, L. N.
    Sterman, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [10] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
12345